SCHEMBL12021216

SCHEMBL12021216

COC(=O)C[C@H](C=O)c1ccc(OCc2cccc(-c3ccc(C)cc3)c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 19/20 0.55
▸ ANO1 Q5XXA6 1/20 0.46
▸ GNA15 P30679 1/20 0.44
▸ AKR1B1 P15121 1/20 0.44
▸ FFAR4 Q5NUL3 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12021215 0.90 FFAR1 (0.53) FFAR1ANO1GNA15AKR1B1FFAR4
SCHEMBL12021118 0.88 FFAR1 (0.64) FFAR1
SCHEMBL17386331 0.82 MAOB (0.54) FFAR1
SCHEMBL17386334 0.82 MAOB (0.54) FFAR1
SCHEMBL14980205 0.80 FFAR1 (0.63) FFAR1
SCHEMBL14273217 0.80 FFAR1 (0.63) FFAR1
SCHEMBL12021109 0.79 FFAR1 (0.62) FFAR1
SCHEMBL12348753 0.78 FFAR1 (0.61) FFAR1
SCHEMBL17429707 0.78 MAPT (0.42) FFAR1
SCHEMBL5944103 0.76 FFAR1 (0.64) FFAR1ANO1AKR1B1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893582-B1 Compounds, their pharmaceutical compositions and their use in treating metabolic disorders AMGEN INC (US) 2011-12-14 — — EP disclosed
Send feedback